In the last year, the antibody therapeutics space has explored new targets in oncology and beyond. Meanwhile, COVID-19 has provided further opportunities for advancements in therapeutic antibody discovery and development. However, where has the industry seen the biggest changes?
Antibody Engineering & Therapeutics is conducting a global survey to find out how antibody engineering and antibody-based therapeutics have now developed across the biotech space. The final report will reveal the existing and new challenges the industry is currently facing, alongside trends and opportunities for further innovation.
Completing the survey will take just a few minutes and will give you exclusive early access to the final report. All answers will remain anonymous and everyone who completes the survey by Sunday 2 May 2021 will be entered into a prize draw for a free pass to an upcoming Antibody Engineering & Therapeutics conference.